Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase)

NCT04278586 is registered in ClinicalTrials.gov with Cambridge Health Alliance as lead sponsor.

NCT NCT04278586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04278586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase)
Lead sponsor
Cambridge Health Alliance
Phase
Not applicable
Overall status
Completed
Start date
February 15, 2021
Completion date
September 19, 2023
Enrollment
260 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, opioid-use disorder, pain interference, stress related disorder